drugset
drugset / Trial / NCT04075526

Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty

NCT04075526 ↗

Phase 1 Completed 2129 enrolled NYU Langone Health
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized, controlled, open label, parallel four-arm design, multi-center study to compare different intraoperative interventions in the prevention of acute PJI development.

Timeline

Start
2019-10-01
Primary completion
2024-01-01
Completion
2025-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 0.35 % —
Subject Vancomycin Other / unclassified 2 g Topical

Indications

osteoarthritis